Related Experiment Videos

Tetracyclines induce apoptosis in osteoclasts

J T Bettany1, N M Peet, R G Wolowacz

  • 1Smith & Nephew Group Research Centre, York Science Park, Heslington, UK.

Bone
|June 24, 2000
PubMed

Insights

Chemically modified tetracyclines (CMTs) induce osteoclast apoptosis and inhibit bone resorption. This apoptosis mechanism, demonstrated by CMT-3 and doxycycline, offers new insights into tetracycline

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Chemically modified tetracyclines (CMTs) are recognized for inhibiting bone resorption.
  • Their mechanism is primarily attributed to the inhibition of matrix metalloproteinases.

Purpose of the Study:

  • To investigate the potential of tetracyclines to induce apoptosis in osteoclasts.
  • To evaluate the effect of specific CMTs and doxycycline on osteoclast differentiation and activity.

Main Methods:

  • Treatment of mature rabbit osteoclasts with CMT-3 and doxycycline to assess apoptosis.
  • Murine osteoblast/marrow cocultures were used to evaluate the impact of CMT-3 and doxycycline on osteoclast formation and resorption over 11 days.

Main Results:

  • CMT-3 and doxycycline significantly increased osteoclast apoptosis in rabbit osteoclast cultures.
  • CMT-3 and doxycycline reduced mature osteoclast formation and inhibited bone resorption in murine cocultures.
  • CMT-2 and CMT-5 did not demonstrate significant effects on osteoclast viability.

Conclusions:

  • Tetracyclines, including specific CMTs and doxycycline, possess the ability to induce osteoclast apoptosis.
  • Osteoclast apoptosis is an additional mechanism contributing to the bone resorption inhibitory effects of tetracyclines.

Related Concept Videos